Claims Of Cardiovascular Benefits Of HRT May Be Premature, Researcher Says
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Claims Of Cardiovascular Benefits Of HRT May Be Premature, Researcher Says

LONDON, UK -- October 1, 1999 -- It is too early to recommend hormone replacement therapy (HRT) for the prevention of cardiovascular disease, concludes a Swedish study in this week’s British Medical Journal. Dr. Kerstin Rödström from Gothenburg University and colleagues report that women who used HRT were at a lower risk of cardiovascular problems before the start of their treatment than women who did not use HRT.

The research team studied 1201 women over a 24 year period and found that 14.9 per cent of them used HRT at some point over the study period. Before the start of their treatment, these women, say the authors, had significantly lower blood pressure, were less obese and belonged to a higher social group than the women who did not use HRT.

Rödström et al report that over the last thirty years, many studies have reported beneficial effects of postmenopausal hormone replacement therapy on morbidity and mortality from cardiovascular disease - some indicating an almost fifty per cent risk reduction. The authors say that, based on their findings, reports suggesting beneficial effects of HRT during menopause are likely to have been confounded by the pre-existing differences in the health of users as opposed to non-users - ie. users of HRT tend to be women who are less at risk of cardiovascular disease from the outset of their treatment.

On the basis of their findings, say the authors, it is too early to recommend HRT for the prevention of cardiovascular disease before further studies, taking account of such confounding factors, have been conducted.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities